Theis Jeanne L, Sharpe Katharine M, Matsumoto Martha E, Chai High Seng, Nair Asha A, Theis Jason D, de Andrade Mariza, Wieben Eric D, Michels Virginia V, Olson Timothy M
Cardiovascular Genetics Research Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
Circ Cardiovasc Genet. 2011 Dec;4(6):585-94. doi: 10.1161/CIRCGENETICS.111.961052. Epub 2011 Sep 30.
Dilated cardiomyopathy (DCM) is a heritable, genetically heterogeneous disorder that typically exhibits autosomal dominant inheritance. Genomic strategies enable discovery of novel, unsuspected molecular underpinnings of familial DCM. We performed genome-wide mapping and exome sequencing in a unique family wherein DCM segregated as an autosomal recessive (AR) trait.
Echocardiography in 17 adult descendants of first cousins revealed DCM in 2 female siblings and idiopathic left ventricular enlargement in their brother. Genotyping and linkage analysis mapped an AR DCM locus to chromosome arm 7q21, which was validated and refined by high-density homozygosity mapping. Exome sequencing of the affected sisters was then used as a complementary strategy for mutation discovery. An iterative bioinformatics process was used to filter >40,000 genetic variants, revealing a single shared homozygous missense mutation localized to the 7q21 critical region. The mutation, absent in HapMap, 1000 Genomes, and 474 ethnically matched controls, altered a conserved residue of GATAD1, encoding GATA zinc finger domain-containing protein 1. Thirteen relatives were heterozygous mutation carriers with no evidence of myocardial disease, even at advanced ages. Immunohistochemistry demonstrated nuclear localization of GATAD1 in left ventricular myocytes, yet subcellular expression and nuclear morphology were aberrant in the proband.
Linkage analysis and exome sequencing were used as synergistic genomic strategies to identify GATAD1 as a gene for AR DCM. GATAD1 binds to a histone modification site that regulates gene expression. Consistent with murine DCM caused by genetic disruption of histone deacetylases, the data implicate an inherited basis for epigenetic dysregulation in human heart failure.
扩张型心肌病(DCM)是一种遗传性、基因异质性疾病,通常表现为常染色体显性遗传。基因组策略有助于发现家族性DCM新的、意想不到的分子基础。我们对一个独特的家族进行了全基因组定位和外显子组测序,在该家族中DCM作为常染色体隐性(AR)性状分离。
对17名第一代堂兄弟姐妹的成年后代进行超声心动图检查,发现2名女性同胞患有DCM,其兄弟患有特发性左心室扩大。基因分型和连锁分析将一个AR DCM基因座定位到7号染色体长臂21区,通过高密度纯合性定位对其进行了验证和细化。然后,对受影响姐妹的外显子组测序用作发现突变的补充策略。采用迭代生物信息学方法筛选了40000多个遗传变异,发现一个单一的共享纯合错义突变位于7q21关键区域。该突变在HapMap、千人基因组计划及474名种族匹配对照中均未出现,它改变了GATAD1的一个保守残基,GATAD1编码含GATA锌指结构域的蛋白1。13名亲属是杂合突变携带者,即使在高龄时也没有心肌病证据。免疫组化显示GATAD1在左心室心肌细胞中呈核定位,但在先证者中其亚细胞表达和核形态异常。
连锁分析和外显子组测序作为协同基因组策略,将GATAD1鉴定为AR DCM的一个基因。GATAD1与调节基因表达的组蛋白修饰位点结合。与组蛋白去乙酰化酶基因破坏导致的小鼠DCM一致,这些数据提示人类心力衰竭存在表观遗传失调的遗传基础。